openPR Logo
Press release

Insights on the Dengue Vaccine Market to 2022 | Industry Statistics, Emerging Demands, Forecast to 2028

03-23-2022 08:57 AM CET | Health & Medicine

Press release from: Orion Market Research

The global dengue vaccine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Dengue fever is an infectious disease spread by mosquitos that affects both animals and humans. It is caused by the dengue virus, which belongs to the Flaviviridae family and genus Flavivirus. It spreads from one person to another through the bite of an infected Aedes Aegypti mosquito. Dengue fever is characterized by a high temperature, exhaustion, headache, diarrhea, muscle discomfort, skin rashes, anemia, and vomiting. Seizures, yellow skin, and unconsciousness are among symptoms of dengue fever in its most severe form. It has a high death rate and can lead to significant neurological problems. Dengue fever causes CNS symptoms such as aberrant neurological signals, altered consciousness, delirium, and generalized and localized convulsions.

To Request a Sample of our Report on Dengue Vaccine Market: https://www.omrglobal.com/request-sample/dengue-vaccine-market

The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including partnerships and collaborations, mergers and acquisitions, geographical expansion, and new product launches, to remain competitive in the marketplace. For instance, Takeda Pharmaceutical Company Limited announced in March 2021 that the European Medicines Agency (EMA) had accepted the Company's filing packages for its dengue vaccine candidate (TAK-003), which is being investigated for the prevention of dengue due to any dengue virus serotype in people aged four to sixty. During the year 2021, Takeda filed regulatory documents in Argentina, Brazil, Colombia, Indonesia, Malaysia, Mexico, Singapore, Sri Lanka, and Thailand. The tetravalent dengue vaccine candidate (TAK-003) developed by Takeda is based on a live-attenuated dengue serotype 2 virus, which serves as the genetic "backbone" for all four vaccine viruses. TAK-003 produced immunological responses against all four dengue serotypes in both seropositive and seronegative subjects, which lasted for 48 months following vaccination, according to clinical Phase 2 results in children and adolescents. The vaccine was also shown to be generally safe and well tolerated.

Market Coverage

· The market number available for - 2021-2027

· Base year- 2021

· Forecast period- 2022-2028

Segment Covered-

· By Product

· By End-User

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Sanofi S.A., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd, and Merck & Co. Inc., among others.

(Get 15% Discount on Buying this Report)

A full Report of Dengue Vaccine Market is Available @ https://www.omrglobal.com/industry-reports/dengue-vaccine-market

Global Dengue Vaccine Market Report by Segment

By Drug Type

· CYD-TDV [Dengvaxia]

· Others

By End-User

· Government Institutes,

· Specialty Clinics

· Hospitals

· Others

Global Dengue Vaccine Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insights on the Dengue Vaccine Market to 2022 | Industry Statistics, Emerging Demands, Forecast to 2028 here

News-ID: 2584481 • Views:

More Releases from Orion Market Research

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This
Portable Ultrasound Device Market : A Guide to Understanding the Process
Portable Ultrasound Device Market : A Guide to Understanding the Process
Portable ultrasound device market was valued at approximately USD 2.16 billion, and it is projected to reach around USD 3.94 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 6.20% from 2024 to 2033. Portable Ultrasound Device Market Overview The portable ultrasound device market is experiencing significant growth, driven by advancements in imaging technology, the increasing demand for point-of-care diagnostics, and the rising prevalence of chronic diseases. These compact

All 5 Releases


More Releases for Dengue

Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth? The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate? In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,
Dengue Vaccine Market : An Detailed Overview
Introduction: Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the
Dengue Vaccine Market : An Overview
Introduction: Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual. It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240 The report provides a comprehensive analysis of company profiles listed below: - Sanofi - Takeda Dengue Vaccines Market Segment by